Lucid Diagnostics Inc.
Lucid Diagnostics Inc. (LUCD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LUCD · as of Jun 9, 2026
Key Statistics
Explore Lucid Diagnostics Inc. Data
lucd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The LUCD analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $2.00, representing +108.75% upside from the current price of $0.96.
Competitors & Peers
lucd competitorsLUCD
APYX
AVR
IRD
IXHL
OWLTStock Performance
Full HistoryAbout Lucid Diagnostics Inc.
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux diseas…
what is lucid diagnostics inc. · lucd stock overview · lucid diagnostics inc. company profile · who is lucid diagnostics inc. ceo · lucd NASDAQ · lucid diagnostics inc. headquarters · lucid diagnostics inc. business segments
About Stock Overview & Key Data
Lucid Diagnostics Inc. (LUCD) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 14, 2021. As of the latest trading session, LUCD stock price is $0.96, with a market capitalization of $98.0M. The stock has returned -26.30% over the past 12 months and -12.10% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Lucid Diagnostics Inc. stock is Buy, with an average 12-month price target of $2.00. In fiscal year 2025, Lucid Diagnostics Inc. reported revenue of $4.7M and net income of -$58.0M. For detailed data — including Lucid Diagnostics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lucid Diagnostics Inc. (LUCD) stock price is $0.96. The stock is traded on NASDAQ under the ticker symbol LUCD. The 52-week range is $0.90 – $1.63.